The study found that artemisinin can protect against renal damage in DN by inhibiting the expression of TGF-β1 protein in kidney tissue, activating the Nrf2 signaling pathway, and enhancing the expression of antioxidant proteins [36]. The gene discussed is NFE2L2; the disease is liver dysplastic nodule.